James Michael Rossetti DO

Hematologic Oncology

Physician

4815 Liberty AveSte GR70Pittsburgh, PA 15224
Phone+1 412-578-4484
Fax+1 412-235-1030

Dr. Rossetti is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rossetti's full profile Already have an account?

Education & Training

Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2001 - 2004
St Francis Medical CenterResidency, Internal Medicine, 1998 - 2001
Lake Erie College of Osteopathic Medicine - Seton HillClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State License 1999 - 2026
OH State License 2016 - 2018
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.
Harinder Gill, Abdulraheem Yacoub, Aaron T Gerds, Jake Shortt, James M Rossetti
Blood Advances. 2026-07-14
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.
Harinder Gill, Francesca Palandri, David M Ross, Joachim R Göthert, Tara Cochrane
Blood Advances. 2026-05-26
A 40-Year-Old With Prior Stem Cell Transplant for Chronic Myeloid Leukemia Presents With Dyspnea and Respiratory Failure.
Hiam Naiditch, Hilary Strollo, Vanessa Gipson, Gabriel Sica, Urvashi Joshi
Chest. 2025-02-01

Press Mentions

Myelofibrosis: More Than Meets the Eye?May 2nd, 2024
Genetics and Genetic Testing to Inform Myelofibrosis Clinical ManagementMay 4th, 2024
Myelofibrosis: Beyond RuxolitinibJune 11th, 2024